NONobukazu Okimoto

Nobukazu Okimoto

*This is an algorithmically generated author record based on publicly available information.

Nobukazu Okimoto has a total of 247 co-authors. Here are the top co-authors by number of shared publications:

  • Toshitaka Nakamura

    Department of Orthopedic Surgery, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan

    21 shared publications
  • Yuichi Okazaki

    Department of Orthopaedic Surgery, Tobata General Hospital, Kitakyushu, Japan

    15 shared publications
  • Akinori Sakai

    Department of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Fukuoka, 807-8555, Japan

    12 shared publications
  • Makoto Kawasaki

    Department of Orthopaedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

    9 shared publications
  • Satoshi Ikeda

    Department of Orthopedic Surgery, Ken-Ai Memorial Hospital, 1191 Kimori, Onga-cho, Onga, Fukuoka, 811-4313, Japan

    7 shared publications
  • Akinori Sakai

    Department of Orthopaedic Surgery, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan

    6 shared publications

Latest Publications

  • Open Access

    Distribution and Characteristics of Fall Risk Index-21 Scores in Patients with Fall-Related Hip Fractures

    by Norifumi Fujii, Manabu Tsukamoto, Ryoichi Nakamura, Sachio Himei, Daisuke Nakagawa, Yoshiaki Ikejiri, Toru Yoshioka, Takayuki Nabeshima, Nobukazu Okimoto

    Background: Fall risk assessment and preventive interventions are important for preventing secondary fractures after hip fracture. The aim of this study was to investigate the distribution and characteristics of Fall Risk Index-21 (FRI-21) scores based on prefracture living conditions in patients with fall-related unilateral hip fracture.Methods: This study included 95 people who had suffered a hip fracture after a fall and had undergone surgery. FRI-21, dual energy X-ray absorptiometry (DXA), and hip structure analysis/trabecular bone score based on DXA were performed within 1 week after surgery. We compared bone parameters between the two groups, which were divided according to the cutoff value of the FRI-21. We also performed cluster analysis on the components of the FRI-21 and compared the characteristics of the subgroups via analysis of variance and multiple comparison tests.Results: All participants had experienced a fall-related fracture, but 47 (49.5%) of the patients were judged to have low scores (<10) on the FRI-21. Moreover, cluster analysis revealed that the subjects were classified into three subgroups, and the characteristics of the items that constitute fall risk, namely, physical function, disease or geriatric syndrome, and environmental factors, were diverse.Conclusions: These results suggest that caution is needed when interpreting the FRI-21 total score based on preoperative living conditions in post-fracture patients, as it may not adequately reflect fall risk. Considering the characteristics of the FRI-21 score in patients with hip fractures, identifying appropriate fall prevention strategies and healthcare professionals involved may be important for preventing future re-fractures.

  • Open Access

    Trends of clinical vertebral and hip fractures following local government involvement in fracture prevention from 2015 to 2021 in Kure, Japan

    by Toshiyuki Mizuno, Manabu Tsukamoto, Hidefumi Teramoto, Takahiko Hamasaki, Taizan Shirakawa, Tsuyoshi Nakagawa, Takuma Yamasaki, Junya Tsukisaka, Nobuo Adachi, Saeko Fujiwara, et al.

    Summary Community-wide Fracture Liaison Services and educational outreach to local physicians on osteoporosis can effectively reduce the fragility fracture burden at the population level in a super-aged society. Purpose Effective prevention of osteoporosis and fractures requires not only implementing a Fracture Liaison Service (FLS) but also enhancing osteoporosis awareness among local physicians, residents, and the municipality. We examined the impact of multidisciplinary, municipality-supported FLS and osteoporosis awareness activities on the incidence of clinical vertebral and hip fractures in a rapidly ageing urban Japanese population. Methods We conducted a population-based pre-post observational study of residents aged ≥ 65 years in Kure, Japan, following the introduction of community-wide FLS and osteoporosis awareness activities. Residents were enrolled in the National Health Insurance or Senior Elderly Care System between 2015 and 2021. Fracture events were identified using insurance claims data and ICD/treatment codes. Results Overall, the incidence of clinical vertebral fractures tended to increase until 2017 and then tended to decrease thereafter; the incidence of hip fractures tended to decrease after 2017 in females but not in males. Compared with the incidence in 2017, the age–sex-adjusted incidence ratio was 0.76 (95% CI 0.70–0.83) for clinical vertebral fractures and 0.87 (95% CI 0.78–0.96) for hip fractures in 2015. In 2021, the incidence ratio was 0.89 (95% CI 0.82–0.96) for clinical vertebral fractures and 0.85 (95% CI 0.76–0.94) for hip fractures. During this period, an increase in the number of prescriptions and changes in the prescribing patterns were observed. Conclusions Significant reductions in the incidence of both clinical vertebral and hip fractures among women were demonstrated after the launch of a comprehensive fracture prevention project supported by the local government.

  • Effects of differences in dose and frequency of teriparatide on bone structure in Proximal Femur. – Analysis by DXA-based 3D-modeling (3D-SHAPER Software) –TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineraL density increase and BONE structure)

    by Junichi Takada, Nobukazu Okimoto, Manabu Tsukamoto, Tomohiro Akatsuka, Tsuneo Takebayashi, Kousuke Iba, Satoshi Ikeda

    Trends toward more favorable improvement of the cortical bone parameters by once-weekly (56.5 mu g once a week) and twice-weekly teriparatide (28.2 mu g twice a week), and that of the trabecular bone parameters by once-daily (1/D) teriparatide (20 mu g/day once a day) were shown. Purpose To examine the effects of differences in the amount of teriparatide (TPTD) per administration and its dosing frequency on the bone structure in the proximal femur by dual-energy X-ray absorptiometry (DXA)-based 3D-modeling (3D-SHAPER software). Methods This was a multicenter retrospective study. Patients aged 50 years or older with primary osteoporosis who continuously received once-/twice-weekly (1.2/W, n = 60) or 1/D TPTD (n = 14) administration for at least one year were included in the study. Measurement regions included the femoral neck (FN), trochanter (TR), femoral shaft (FS), and total proximal hip (TH). Concurrently, the bone mineral density (BMD) and Trabecular Bone Score (TBS) were measured. Results The cross-sectional area, cross-sectional moment of inertia, and section modulus in the FS were significantly improved in the 1.2/W TPTD group, as compared to the 1/D TPTD group. However, significant improvement of the cortical thickness and buckling ratio in the FN was observed in the 1/D TPTD group, as compared to the 1.2/W TPTD group. Trabecular BMD values in the FS and TH were significantly increased in the 1/D TPTD group, as compared to the 1.2/W TPTD group, while the cortical BMD values in the TR, FS, and TH were significantly increased in the 1.2/W TPTD group, as compared to the 1/D TPTD group. ConclusionTrends toward more favorable improvement of the cortical bone by 1.2/W TPTD and that of the trabecular bones by 1/D TPTD were observed.


  • Open Access

    Body Part Pain Affects Subjective and Objective Handball Performance in Japanese Male National Athletes—Results of Short-Term Practical Monitoring of Athletes’ Conditions

    by Issei Ogasawara, Daichi Shindo, Kazuki Fujiwara, Haruka Suzuki, Yuki Ueno, Hiroyuki Kato, Michihiro Takada, Yusuke Adachi, Manabu Todoroki, Susumu Iwasaki, et al.

    This short-term survey examined the effect of body part pain on subjective and objective handball performance in Japanese male national handball athletes. Fourteen athletes participated in this study. Assessments of pain in 10 body parts and subjective performance (concentration and satisfaction with body movement) were performed using a visual analog scale from 0 to 10 over four consecutive training days. Monitoring of heart rate and body acceleration during training was also performed to quantify the objective performance. Path analysis and linear mixed modeling were employed to assess the relationship between body pain scores and subjective/objective handball performance. Over the four days of the study period, the body part in which most athletes reported pain was the dominant shoulder (6 of 14 athletes), followed by the dominant knee, the dominant elbow, the dominant ankle joint, and the non-dominant ankle joint (3 of 14 athletes). The path analysis revealed that pain in the dominant elbow negatively correlated with concentration (standardized path coefficient = −0.644, p = 0.00), which was associated with satisfaction with body movement (standardized path coefficient = 0.704, p = 0.00). No significant effect of body pain on objective performance (heart rate and body acceleration) was found among the athletes in this study. The results suggested that the elite athletes were practicing with pain. Even if pain does not physically affect athletes’ objective performance, pain in the upper extremities, associated with the primary handball movement of throwing, may reduce the quality of practice by lowering athletes’ subjective performance.


  • Open Access

    The effects of abaloparatide on hip geometry and biomechanical properties in Japanese osteoporotic patients assessed using DXA-based hip structural analysis: results of the Japanese phase 3 ACTIVE-J trial

    by Teruki Sone, Kazuhiro Ohnaru, Takumi Sugai, Akiko Yamashita, Nobukazu Okimoto, Tetsuo Inoue, Toshio Matsumoto

    Summary Daily subcutaneous injection of 80 μg abaloparatide increased bone mineral density in Japanese patients with osteoporosis at high fracture risk in the ACTIVE-J trial. Dual-energy X-ray absorptiometry–based hip structural analysis from ACTIVE-J data showed improved hip geometry and biomechanical properties with abaloparatide compared with placebo. Purpose Abaloparatide (ABL) increased bone mineral density (BMD) in Japanese patients with osteoporosis at high fracture risk in the ACTIVE-J trial. To evaluate the effect of ABL on hip geometry and biomechanical properties, hip structural analysis (HSA) was performed using ACTIVE-J trial data. Methods Hip dual-energy X-ray absorptiometry scans from postmenopausal women and men (ABL, n = 128; placebo, n = 65) at baseline and up to week 78 were analyzed to extract bone geometric parameters at the narrow neck (NN), intertrochanteric region (IT), and proximal femoral shaft (FS). Computed tomography (CT)-based BMD and HSA indices were compared between baseline and week 78. Results ABL treatment showed increased mean percent change from baseline to week 78 in cortical thickness at the NN (5.3%), IT (5.3%), and FS (2.9%); cross-sectional area at the NN (5.0%), IT (5.0%), and FS (2.6%); cross-sectional moment of inertia at the NN (7.6%), IT (5.1%), and FS (2.5%); section modulus at the NN (7.4%), IT (5.4%), and FS (2.4%); and decreased mean percent change in buckling ratio (BR) at the IT (− 5.0%). ABL treatment showed increased mean percent change in total volumetric BMD (vBMD; 2.7%) and trabecular vBMD (3.2%) at the total hip and decreased mean percent change in BR at femoral neck (− 4.1%) at week 78 vs baseline. All the changes noted here were significant vs placebo (P < 0.050 using t-test). Conclusion A 78-week treatment with ABL showed improvement in HSA parameters associated with hip geometry and biomechanical properties vs placebo. Trial registration JAPIC CTI-173575


  • Open Access

    Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan

    by Takahiro Kunihara, Hidetoshi Tohmori, Manabu Tsukamoto, Masashi Kobayashi, Toshiya Okumura, Hidefumi Teramoto, Takahiko Hamasaki, Takuma Yamasaki, Tsuyoshi Nakagawa, Nobukazu Okimoto, et al.

    Summary We investigated the incidence/trend of osteonecrosis of the jaw by antiresorptive agent dose over a 5-year period in Kure city, Japan. The incidence was 24 times higher among osteoporosis patients with low-dose agents and 421 times higher among cancer patients with high-dose agents than in the population without agents. Purpose We launched the registry system of osteonecrosis of the jaw (ONJ) cases in 2015 to investigate the trend in ONJ incidence. The purpose of our study was to estimate the ONJ incidence among patients with antiresorptive agent use by dosage and people without antiresorptive agent use in Kure and its trend from 2016 to 2020. Methods From 2016 to 2021, 98 eligible ONJ patients were enrolled. Medication-related ONJ (MRONJ) was diagnosed based on the American Association of Oral and Maxillofacial Surgeons criteria. The annual number of those with and without antiresorptive agents was obtained from the claims database. Antiresorptive agents used for cancer and osteoporosis patients were defined as high- and low-dose medications, respectively. Results The annual incidence of high-dose MRONJ was 2305.8 per 100,000 and that of low-dose MRONJ was 132.5 per 100,000, while the ONJ incidence among people without antiresorptive agents was 5.1 per 100,000. The incidence ratio was 23.6 (p < 0.001, 95% confidence interval (CI) 13.3–41.8) among osteoporosis patients who used low-dose antiresorptive agents and 420.6 (p < 0.001, 95% CI 220.8–801.4) among cancer patients who used high-dose agents compared with people who did not use these agents. MRONJ incidence increased from 2016 to 2020, but the incidence of high-dose MRONJ decreased, although this was nonsignificant. Conclusion We demonstrated the incidence and trend of ONJ by antiresorptive agent dose over a 5-year period in Kure after launching the multiprofession study. This collaborative study for the early detection and prevention of ONJ will continue.


  • Open Access

    Daily activity relates to not only femoral bone mineral density, but also hip structural analysis parameters: A cross-sectional observational study

    by Norifumi Fujii, Nobukazu Okimoto, Manabu Tsukamoto, Norimitsu Fujii, Kei Asano, Yoshiaki Ikejiri, Toru Yoshioka, Takafumi Tajima, Yoshiaki Yamanaka, Yukichi Zenke, et al.


  • Open Access

    Successful Reboot of High-Performance Sporting Activities by Japanese National Women’s Handball Team in Tokyo, 2020 during the COVID-19 Pandemic: An Initiative Using the Japan Sports–Cyber Physical System (JS–CPS) of the Sports Research Innovation Project (SRIP)

    by Issei Ogasawara, Shigeto Hamaguchi, Ryosuke Hasegawa, Yukihiro Akeda, Naoki Ota, Gajanan S. Revankar, Shoji Konda, Takashi Taguchi, Toshiya Takanouchi, Kojiro Imoto, et al.

    The COVID-19 pandemic has negatively impacted sporting activities across the world. However, practical training strategies for athletes to reduce the risk of infection during the pandemic have not been definitively studied. The purpose of this report was to provide an overview of the challenges we encountered during the reboot of high-performance sporting activities of the Japanese national handball team during the 3rd wave of the COVID-19 pandemic in Tokyo, Japan. Twenty-nine Japanese national women’s handball players and 24 staff participated in the study. To initiate the reboot of their first training camp after COVID-19 stay-home social policy, we conducted: web-based health-monitoring, SARS-CoV-2 screening with polymerase chain reaction (PCR) tests, real-time automated quantitative monitoring of social distancing on court using a moving image-based artificial intelligence (AI) algorithm, physical intensity evaluation with wearable heart rate (HR) and acceleration sensors, and a self-reported online questionnaire. The training camp was conducted successfully with no COVID-19 infections. The web-based health monitoring and the frequent PCR testing with short turnaround times contributed remarkably to early detection of athletes’ health problems and to risk screening. During handball, AI-based on-court social-distance monitoring revealed key time-dependent spatial metrics to define player-to-player proximity. This information facilitated appropriate on- and off-game distancing behavior for teammates. Athletes regularly achieved around 80% of maximum HR during training, indicating anticipated improvements in achieving their physical intensities. Self-reported questionnaires related to the COVID management in the training camp revealed a sense of security among the athletes that allowed them to focus singularly on their training. The challenges discussed herein provided us considerable knowledge about creating and managing a safe environment for high-performing athletes in the COVID-19 pandemic via the Japan Sports–Cyber Physical System (JS–CPS) of the Sports Research Innovation Project (SRIP, Japan Sports Agency, Tokyo, Japan). This report is envisioned to provide informed decisions to coaches, trainers, policymakers from the sports federations in creating targeted, infection-free, sporting and training environments.


  • Open Access

    Zoledronic acid sequential therapy could avoid disadvantages due to the discontinuation of less than 3-year denosumab treatment

    by Hideomi Kondo, Nobukazu Okimoto, Toru Yoshioka, Shojiro Akahoshi, Yoshifumi Fuse, Takayuki Ogawa, Yuichi Okazaki, Yuji Katae, Manabu Tsukamoto, Yoshiaki Yamanaka, et al.

    Introduction Rapid descent in bone mineral density (BMD) and ascent in bone turnover marker (BTM) occur within the short period following denosumab (Dmab) discontinuation. In addition, the incidence of vertebral fracture also rises within the short period. The purpose of this study is to investigate the effects of sequential therapy using zoledronic acid (ZOL) on any adverse events after Dmab discontinuation. Materials and methods This study was a multicenter retrospective observational study, and the subjects were osteoporosis patients who visited our institutions between 2013 and 2018. We performed sequential therapy using ZOL for 30 patients who had difficulty continuing Dmab, due to physical or social reasons, and investigated the fracture incidence and BMD/BTM changes at 4 time points (at the start of Dmab, the start of ZOL, 6 months after ZOL and 12 months after ZOL). Results No new vertebral/nonvertebral fractures were observed at each time point after switching from Dmab to ZOL in any of the 30 patients. The BMD/BTM changes were evaluated in 18 of the 30 cases, since all data of lumbar/femoral neck BMDs and TRACP-5b at 4 time points was only available in 18 cases. BMDs significantly increased at each time point compared with that at the start of Dmab. Serum TRACP-5b significantly decreased at each time point compared with that at the start of Dmab. Conclusion It was suggested that sequential therapy using ZOL could suppress the decrease of BMD, and increase of BTM, if the period of Dmab administration was less than 3 years.


  • Efficacy of non-steroidal anti-inflammatory drugs on zoledronic acid-induced acute-phase reactions: randomized, open-label, Japanese OZ study

    by Nobukazu Okimoto, Akinori Sakai, Toru Yoshioka, Tomohiro Kobayashi, Kei Asano, Shojiro Akahoshi, Toru Ishikura, Shito Fukuhara, Yoshifumi Fuse, Toshiyuki Mizuno, et al.

    Zoledronic acid infusion is used to treat osteoporosis but patients, especially Japanese patients, often experience acute-phase reactions (APRs). In this multicenter, randomized, open-label, parallel-group study, we examined the efficacy of the most commonly used non-steroidal anti-inflammatory drug loxoprofen in Japan in reducing the incidence rate of zoledronic acid-induced APRs and body temperature, and investigated risk/protective factors for APRs in this population.